Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lily Hoang

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Marine Biotechnology (New York, N.Y.)|February 13, 2004
Characterization of muscle-regulatory genes, Myf5 and myogenin, from striped bass and promoter analysis of muscle-specific expressionXungang Tan, Lily Hoang, Shao Du
Genetics in Medicine : Official Journal of the American College of Medical Genetics|December 15, 2021
Suspected clonal hematopoiesis as a natural functional assay of TP53 germline variant pathogenicityCristina Fortuno, Kelly McGoldrick, Tina Pesaran, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|May 21, 2019
Genotype-phenotype associations among panel-based TP53+ subjectsHuma Q Rana, Jacob Clifford, Lily Hoang, et al.
Scientific Reports|August 13, 2020
Prevalence of pathogenic variants in DNA damage response and repair genes in patients undergoing cancer risk assessment and reporting a personal history of early-onset renal cancerTiffiney R Hartman, Elena V Demidova, Randy W Lesh, et al.
JAMA Oncology|November 4, 2023
Diagnostic Outcomes of Concurrent DNA and RNA Sequencing in Individuals Undergoing Hereditary Cancer TestingCarolyn Horton, Lily Hoang, Heather Zimmermann, et al.
JCO Precision Oncology|January 3, 2022
Association of Family Cancer History With Pathogenic Variants in Specific Breast Cancer Susceptibility GenesAllison W Kurian, Paul Abrahamse, Kevin C Ward, et al.
JAMA|June 5, 2023
Germline Genetic Testing After Cancer DiagnosisAllison W Kurian, Paul Abrahamse, Allison Furgal, et al.
NPJ Genomic Medicine|August 25, 2022
Mutational and splicing landscape in a cohort of 43,000 patients tested for hereditary cancerCarolyn Horton, Ashley Cass, Blair R Conner, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|August 14, 2019
A clinical guide to hereditary cancer panel testing: evaluation of gene-specific cancer associations and sensitivity of genetic testing criteria in a cohort of 165,000 high-risk patientsHolly LaDuca, Eric C Polley, Amal Yussuf, et al.
JAMA Network Open|October 24, 2019
Assessment of Diagnostic Outcomes of RNA Genetic Testing for Hereditary CancerRachid Karam, Blair Conner, Holly LaDuca, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Marine Biotechnology (New York, N.Y.)|February 13, 2004
Characterization of muscle-regulatory genes, Myf5 and myogenin, from striped bass and promoter analysis of muscle-specific expressionXungang Tan, Lily Hoang, Shao Du
Genetics in Medicine : Official Journal of the American College of Medical Genetics|December 15, 2021
Suspected clonal hematopoiesis as a natural functional assay of TP53 germline variant pathogenicityCristina Fortuno, Kelly McGoldrick, Tina Pesaran, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|May 21, 2019
Genotype-phenotype associations among panel-based TP53+ subjectsHuma Q Rana, Jacob Clifford, Lily Hoang, et al.
Scientific Reports|August 13, 2020
Prevalence of pathogenic variants in DNA damage response and repair genes in patients undergoing cancer risk assessment and reporting a personal history of early-onset renal cancerTiffiney R Hartman, Elena V Demidova, Randy W Lesh, et al.
JAMA Oncology|November 4, 2023
Diagnostic Outcomes of Concurrent DNA and RNA Sequencing in Individuals Undergoing Hereditary Cancer TestingCarolyn Horton, Lily Hoang, Heather Zimmermann, et al.
JCO Precision Oncology|January 3, 2022
Association of Family Cancer History With Pathogenic Variants in Specific Breast Cancer Susceptibility GenesAllison W Kurian, Paul Abrahamse, Kevin C Ward, et al.
JAMA|June 5, 2023
Germline Genetic Testing After Cancer DiagnosisAllison W Kurian, Paul Abrahamse, Allison Furgal, et al.
NPJ Genomic Medicine|August 25, 2022
Mutational and splicing landscape in a cohort of 43,000 patients tested for hereditary cancerCarolyn Horton, Ashley Cass, Blair R Conner, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|August 14, 2019
A clinical guide to hereditary cancer panel testing: evaluation of gene-specific cancer associations and sensitivity of genetic testing criteria in a cohort of 165,000 high-risk patientsHolly LaDuca, Eric C Polley, Amal Yussuf, et al.
JAMA Network Open|October 24, 2019
Assessment of Diagnostic Outcomes of RNA Genetic Testing for Hereditary CancerRachid Karam, Blair Conner, Holly LaDuca, et al.
Pageof 2